Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention.
Yoshihiro OnoYosuke InoueTomotaka KatoKiyoshi MatsuedaAtsushi ObaTakafumi SatoHiromichi ItoAkio SaiuraYu TakahashiPublished in: Cancers (2021)
To achieve curative resection for pancreatic cancer during pancreaticoduodenectomy (PD), extensive portal vein (PV) resection, including porto-mesenterico-splenic confluence (PMSC), may sometimes be necessary if the tumor is close to the portal venous system. Recently, this extended resection has been widely accepted in high-volume centers for pancreatic resection due to its favorable outcomes compared with non-operative treatment. However, in patients with long-term survival, sinistral portal hypertension (SPH) occurs as a late-onset postoperative complication. These patients present gastrointestinal varices due to congested venous flow from the spleen, which may cause critical variceal bleeding. Since the prognosis of patients with pancreatic cancer has improved, owing to the development of chemotherapy and surgical techniques, SPH is no longer a negligible matter in the field of pancreatic cancer surgery. This review clarifies the pathogenesis and frequency of SPH after PD through PMSC resection and discusses its prediction and prevention.
Keyphrases
- late onset
- blood pressure
- end stage renal disease
- minimally invasive
- early onset
- type diabetes
- prognostic factors
- squamous cell carcinoma
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- coronary artery bypass
- acute coronary syndrome
- patient reported outcomes
- smoking cessation
- glycemic control